A 6-month, subject-masked, randomized controlled study to assess efficacy of dexamethasone as an adjunct to bevacizumab compared with bevacizumab alone in the treatment of patients with macular edema due to central or branch retinal vein occlusion

AIMS: To determine if intravitreal bevacizumab combined with the dexamethasone intravitreal implant 0.7 mg improves visual acuity and macular thickness more than bevacizumab monotherapy in eyes with macular edema due to branch and central retinal vein occlusions. METHODS: Thirty eyes were randomly a...

Descripción completa

Detalles Bibliográficos
Autores principales: Maturi, Raj K, Chen, Vincent, Raghinaru, Dan, Bleau, Laurie, Stewart, Michael W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4051812/
https://www.ncbi.nlm.nih.gov/pubmed/24940042
http://dx.doi.org/10.2147/OPTH.S60159

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4051812/
https://www.ncbi.nlm.nih.gov/pubmed/24940042
http://dx.doi.org/10.2147/OPTH.S60159

Ejemplares similares